Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Takeda
Children's Oncology Group
University College, London
Fondazione Italiana Linfomi - ETS
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
University College, London
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Shandong University
Children's Oncology Group
Inovio Pharmaceuticals
National Institute of Allergy and Infectious Diseases (NIAID)
Fondazione Michelangelo
Children's Oncology Group
M.D. Anderson Cancer Center
University of Cologne
Canadian Cancer Trials Group
University of Cologne
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Lymphoma Study Association
Nanfang Hospital, Southern Medical University
Children's Oncology Group
French Innovative Leukemia Organisation
Fondazione Michelangelo
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service